Document is current
Any future updates will be listed below
-
Authors
Massinga, Arsénia J.
Garrine, Marcelino
Messa, Augusto Jr
Nobela, Nélio A.
Boisen, Nadia
Massora, Sergio
Cossa, Anélsio
Varo, Rosauro
Sitoe, António
Hurtado, Juan Carlos
Ordi, Jaume
Mucavele, Hélio
Nhampossa, Tacilta
Breiman, Robert F.
Whitney, Cynthia G.
Blau, Dianna M.
Bassat, Quique
Mandomando, Inácio
- License Information
-
More Information
Article History
Received: 26 January 2021
Accepted: 20 May 2021
First Online: 5 June 2021
Declarations
:
: The protocol of invasive bacterial disease surveillance (IBD) was reviewed and approved by the Mozambican National Bioethics Committee for Health and Institutional Review Boards of Hospital Clinic of Barcelona, Spain, the U.S. Centers for Disease Control and Prevention, and the University of Maryland, School of Medicine. The CHAMPS was reviewed and approved by the CISM’s Institutional Ethics Committee for Health – CIBS-CISM and the CNBS (Ref: 285/CNBS/16 of September 05, 2016).The isolates included in this research were obtained from participants who were enrolled in the IBD and CHAMPS, and only if the parents, caretaker or legal guardians accepted to participate and sign an informed consent.The IBD and CHAMPS protocol and its methods were performed in accordance with the Declaration of Helsinki and Good Clinical and Laboratory Practices.
: Not applicable.
: The authors declare that they have no competing interests.
